Enzymes and General Principles of Metabolism: Catalysis, Kinetics, Inhibition, Regulation, Coenzymes and ATP

This chapter answers Section XL1.2 of XL1 Biochemistry, one of the five optional sections of the Life Sciences (XL) paper: “Enzymes: catalysis, specificity, and regulation, kinetics (up to two substrates), enzyme inhibitors; Regulatory Enzymes; Vitamins and coenzymes; General principles of metabolism, hormonal regulation of metabolism; Generation and utilization of ATP.” It teaches how enzymes lower the activation barrier and choose their substrates, Michaelis–Menten and two-substrate kinetics, the kinds of inhibition and their use as drugs, allosteric and covalent control, the vitamins behind the coenzymes, the logic of metabolic and hormonal control, and how ATP is made and spent. The numericals are Km and Vmax from rates and Lineweaver–Burk plots, Ki, kcat and kcat/Km, and the free energy of ATP hydrolysis under cellular conditions.

1. Catalysis and specificity

An enzyme speeds a reaction by lowering the activation free energy ΔG‡. It does not change ΔG°′, the equilibrium constant or the position of equilibrium, so it speeds the forward and reverse reactions equally. Rate depends exponentially on ΔG‡: lowering it by 5.7 kJ mol⁻¹ at 25 °C raises the rate tenfold. The energy comes from binding: the active site is complementary to the transition state rather than to the substrate, so many weak interactions form only as the substrate is distorted towards it, which is why transition-state analogues are potent inhibitors. Chemical strategies add to this: general acid–base catalysis (the histidines of ribonuclease A), covalent catalysis (Ser195 of chymotrypsin), metal-ion catalysis (Zn²⁺ of carboxypeptidase A) and holding reacting groups close together in the right orientation.

Specificity comes from the shape and chemistry of the binding site. Fischer's lock-and-key picture explains complementarity; Koshland's induced fit adds that binding changes the enzyme's conformation and aligns the catalytic groups only for the right substrate. Hexokinase closes around glucose, excluding water and so avoiding wasteful hydrolysis of ATP. Enzymes are stereospecific: they tell D from L isomers and, because a substrate binds at three or more points, even the two identical arms of a symmetrical molecule such as citrate.

The seven EC classes
ClassReactionExample
1 OxidoreductasesTransfer of electrons (hydride or H atoms)Lactate dehydrogenase
2 TransferasesTransfer of a group between moleculesHexokinase, aminotransferases
3 HydrolasesCleavage by waterChymotrypsin, lysozyme
4 LyasesNon-hydrolytic cleavage or addition across a double bondAldolase, fumarase
5 IsomerasesRearrangement within one moleculeTriose phosphate isomerase
6 LigasesJoining two molecules using ATP or another nucleoside triphosphateDNA ligase, pyruvate carboxylase
7 Translocases (added in 2018)Moving ions or molecules across membranesIon-pumping ATPases

2. Michaelis–Menten kinetics

For E + S ⇌ ES → E + P, with rate constants k₁, k₋₁ and k₂ (= kcat), the steady-state assumption ([ES] constant while [S] ≫ [E]) gives the Michaelis–Menten equation v₀ = Vmax[S]/(Km + [S]), where Km = (k₋₁ + k₂)/k₁ and Vmax = kcat[E]T. Km is the substrate concentration at which v₀ = Vmax/2; it equals the dissociation constant of ES only when k₂ ≪ k₋₁. At [S] ≪ Km the rate is first order in S, v₀ ≈ (kcat/Km)[E]T[S]; at [S] ≫ Km it is zero order. Useful fractions: [S] = Km gives 50% of Vmax, 4Km gives 80% and 9Km gives 90%.

  • kcat, the turnover number, is the number of substrate molecules converted per active site per second when the enzyme is saturated.
  • kcat/Km, the specificity constant, is the second-order rate constant for E + S at low [S]. It ranks competing substrates and is capped by diffusion at about 10⁸–10⁹ M⁻¹ s⁻¹, which triose phosphate isomerase and acetylcholinesterase approach.
  • Lineweaver–Burk (double-reciprocal) plot: 1/v₀ = (Km/Vmax)(1/[S]) + 1/Vmax, so the y-intercept is 1/Vmax, the x-intercept −1/Km and the slope Km/Vmax. It overweights the low-[S] points, which carry the largest errors; the Eadie–Hofstee plot (v₀ against v₀/[S], slope −Km) spreads the data more evenly.
🧠 Worked example
Two rates fix both constants. If v₀ = 20 µmol min⁻¹ at 1 mM S and 40 µmol min⁻¹ at 4 mM, write Vmax = v₀(Km + [S])/[S] for both: 20(Km + 1) = 10(Km + 4), so Km = 2 mM and Vmax = 60 µmol min⁻¹. Check: 60 × 4/6 = 40.

3. Kinetics with two substrates

Most enzymes have two substrates (A + B ⇌ P + Q). In sequential mechanisms both substrates bind before any product leaves, forming a ternary complex EAB; binding may be ordered (lactate dehydrogenase binds NADH before pyruvate) or random. In the ping-pong (double-displacement) mechanism the first substrate hands a group to the enzyme and the first product leaves before the second substrate binds, through a substituted enzyme E*. Aminotransferases shuttle the amino group through enzyme-bound pyridoxal phosphate and pyridoxamine phosphate; chymotrypsin's acyl-enzyme follows the same logic.

The mechanisms are told apart by measuring v₀ against [A] at several fixed [B] and plotting 1/v₀ against 1/[A]. Sequential mechanisms give lines that intersect to the left of the 1/v₀ axis, because [B] changes both slope and intercept; ping-pong gives parallel lines, because [B] changes only the intercept. Product inhibition patterns then separate ordered from random binding, and isotope exchange between A and P in the absence of B reveals the substituted enzyme of a ping-pong mechanism.

4. Enzyme inhibitors

A reversible inhibitor binds non-covalently and is characterised by an inhibition constant. Define α = 1 + [I]/Ki for binding to free E and α′ = 1 + [I]/Ki′ for binding to ES.

Reversible inhibition at a glance
TypeBindsApparent VmaxApparent KmLineweaver–Burk lines
CompetitiveFree E, at the active siteUnchangedαKmMeet on the 1/v₀ axis
UncompetitiveES onlyVmax/α′Km/α′Parallel
MixedE and ES, Ki ≠ Ki′Vmax/α′αKm/α′Meet left of the 1/v₀ axis, off the 1/[S] axis
Pure noncompetitiveE and ES equallyVmax/αUnchangedMeet on the 1/[S] axis

Competitive inhibition is overcome by raising [S]; uncompetitive inhibition is not, and grows stronger as [S] rises. Example: 15 µM of a competitive inhibitor raises the apparent Km from 2.0 to 8.0 mM, so α = 4 and Ki = 15/3 = 5 µM. Irreversible inhibitors bond covalently or bind so tightly that dialysis does not remove them, so they reduce the amount of active enzyme: group-specific reagents (diisopropyl fluorophosphate on an active-site Ser, iodoacetamide on Cys), affinity labels (TPCK on His57 of chymotrypsin) and mechanism-based (suicide) inactivators, which the target enzyme itself converts into a reactive form. Many drugs are inhibitors: statins compete with HMG-CoA at HMG-CoA reductase; methotrexate binds dihydrofolate reductase extremely tightly as a folate analogue; aspirin acetylates a Ser of cyclooxygenase; penicillin acylates the transpeptidase that cross-links peptidoglycan; and allopurinol is converted by xanthine oxidase into oxypurinol, which stays bound.

⚠️ Exam trap
A pure noncompetitive inhibitor and an irreversible inactivator both lower Vmax and leave Km unchanged, and their plots look alike. Dialysis or gel filtration tells them apart: activity returns only if the inhibitor was reversible.

5. Regulation and regulatory enzymes

Pathways are controlled at a few committed, usually irreversible steps by regulatory enzymes. Allosteric enzymes have separate regulatory sites, are usually multi-subunit, and give sigmoidal curves of v₀ against [S], described by K0.5 instead of Km; activators shift the curve left and inhibitors right. The classic case is aspartate transcarbamoylase (ATCase) of E. coli, which commits aspartate to pyrimidine synthesis. It has six catalytic and six regulatory chains; CTP, the end product, inhibits it (feedback inhibition) and ATP activates it, balancing purine and pyrimidine supply. Catalytic trimers separated from the regulatory chains stay active but give hyperbolic kinetics and ignore CTP and ATP. Phosphofructokinase-1 is likewise inhibited by ATP and citrate and activated by AMP and fructose 2,6-bisphosphate.

  • Reversible covalent modification, mostly phosphorylation by kinases and its reversal by phosphatases, acts in seconds to minutes: phosphorylation activates glycogen phosphorylase and inactivates glycogen synthase and pyruvate dehydrogenase.
  • Proteolytic activation of zymogens (trypsinogen, chymotrypsinogen, clotting factors) switches an enzyme on once and irreversibly.
  • Isozymes suit kinetics to tissues. Hexokinase I has a Km far below blood glucose and is inhibited by glucose 6-phosphate; glucokinase of liver and pancreatic β-cells is half-saturated only at several millimolar glucose and is not inhibited by glucose 6-phosphate, so it responds to the rise in blood glucose after a meal.
  • Enzyme amount, set by induction, repression and degradation, is the slow control acting over hours.

6. Vitamins and coenzymes

Many enzymes need a non-protein cofactor, either a metal ion or an organic coenzyme; one bound tightly or covalently is a prosthetic group (heme, the FAD of succinate dehydrogenase, biotin). Apoenzyme plus cofactor gives the active holoenzyme. Most water-soluble vitamins are coenzyme precursors, so a deficiency shows up as failure of the reactions that need the coenzyme. Of the fat-soluble vitamins only K acts as a coenzyme; A gives the 11-cis-retinal of rhodopsin, D gives the hormone calcitriol, and E is a membrane antioxidant.

Vitamins, their coenzymes and what fails in deficiency
VitaminCoenzyme formReaction (example)Deficiency
B1 thiamineThiamine pyrophosphateOxidative decarboxylation of α-keto acids (pyruvate dehydrogenase); transketolaseBeriberi; Wernicke–Korsakoff syndrome in alcoholism
B2 riboflavinFMN, FADRedox (succinate and acyl-CoA dehydrogenases)Cheilosis, glossitis
B3 niacinNAD⁺, NADP⁺Hydride transfer by dehydrogenasesPellagra (dermatitis, diarrhoea, dementia)
B5 pantothenateCoenzyme A, acyl carrier proteinAcyl transfer as thioestersRare
B6 pyridoxinePyridoxal phosphateTransamination, amino acid decarboxylation; glycogen phosphorylaseNeuropathy, for example during isoniazid therapy
B7 biotinEnzyme-bound biotinATP-dependent carboxylation (pyruvate carboxylase, acetyl-CoA carboxylase)Rare; avidin of raw egg white binds it
B9 folateTetrahydrofolateOne-carbon transfer (purines, thymidylate)Megaloblastic anaemia; neural tube defects
B12 cobalaminMethylcobalamin, 5′-deoxyadenosylcobalaminMethionine synthase; methylmalonyl-CoA mutaseMegaloblastic anaemia with nerve damage (pernicious anaemia)
C ascorbateAscorbate itself, as reductantProlyl and lysyl hydroxylases of collagenScurvy
KReduced vitamin Kγ-Carboxylation of Glu in clotting factors II, VII, IX, XBleeding; warfarin blocks its recycling

7. General principles of metabolism and its hormonal regulation

Catabolism breaks fuels down, converging on a few intermediates (pyruvate, acetyl-CoA, citric acid cycle intermediates) and conserving energy as ATP and reducing power as NADH and FADH₂; anabolism diverges from these intermediates to build macromolecules, spending ATP and NADPH. Four principles recur. Opposing pathways are never simple reversals: at least one step uses a different, irreversible reaction (phosphofructokinase-1 in glycolysis against fructose 1,6-bisphosphatase in gluconeogenesis), so each direction is favourable, can be regulated on its own, and futile cycling is avoided. Control acts at far-from-equilibrium steps, with large negative ΔG and a mass-action ratio far below K′eq, while near-equilibrium steps simply follow the flux. NADH serves catabolism and NADPH biosynthesis. Compartments separate opposing pathways, such as fatty acid synthesis in the cytosol and β-oxidation in mitochondria.

Hormones that set the fed–fasting switch
HormoneSignal and receptorMain metabolic effects
InsulinHigh blood glucose; receptor tyrosine kinase on liver, muscle, adipose tissueGLUT4 moves to the membrane in muscle and fat; glycogen, fat and protein synthesis rise; gluconeogenesis and lipolysis fall
GlucagonLow blood glucose; mainly liver, through Gs, cAMP and protein kinase AGlycogen breakdown and gluconeogenesis rise; fructose 2,6-bisphosphate falls, slowing glycolysis
EpinephrineStress and exercise; β-adrenergic receptors and cAMP in muscle, liver, fatGlycogen breakdown; glycolysis in muscle; lipolysis in fat
CortisolProlonged stress or fasting; intracellular (nuclear) receptorInduces gluconeogenic enzymes; muscle protein breakdown supplies amino acids

In type 1 diabetes, missing insulin leaves glucagon unopposed: the liver keeps releasing glucose, adipose tissue releases fatty acids, and the liver turns the excess acetyl-CoA into ketone bodies, causing ketoacidosis.

8. Generation and utilisation of ATP

Hydrolysis of ATP to ADP + Pi has ΔG°′ ≈ −30.5 kJ mol⁻¹. Four effects make it large: relief of repulsion between the negatively charged phosphates, resonance stabilisation of free Pi, ionisation of ADP (releasing H⁺ at pH 7) and better solvation of the products. The real substrate of most enzymes is Mg²⁺·ATP. Cells hold [ATP] far above equilibrium, so the actual ΔG = ΔG°′ + RT ln([ADP][Pi]/[ATP]) is about −50 to −65 kJ mol⁻¹. Example at 310 K with ATP 4.0, ADP 0.40 and Pi 2.0 mM: the ratio is 2.0 × 10⁻⁴, ln = −8.52, RT = 2.577 kJ mol⁻¹, so ΔG = −30.5 − 21.95 ≈ −52 kJ mol⁻¹.

Phosphoryl transfer potential (standard ΔG°′ of hydrolysis, kJ mol⁻¹, as tabulated in standard textbooks)
CompoundΔG°′Role
Phosphoenolpyruvate−61.9Makes ATP via pyruvate kinase
1,3-Bisphosphoglycerate−49.3Makes ATP via phosphoglycerate kinase
Phosphocreatine−43.0ATP buffer in muscle (creatine kinase)
ATP → ADP + Pi−30.5Intermediate carrier
Glucose 6-phosphate−13.8Made from ATP by hexokinase
Glycerol 3-phosphate−9.2Made from ATP by glycerol kinase

Compounds above ATP can phosphorylate ADP and ATP can phosphorylate those below it, so ATP is the intermediate carrier of phosphoryl groups. ATP is generated by substrate-level phosphorylation (phosphoglycerate kinase and pyruvate kinase in glycolysis, succinyl-CoA synthetase in the citric acid cycle), by oxidative phosphorylation, in which ATP synthase is driven by the proton-motive force of the respiratory chain, and by photophosphorylation. It is used by coupling: group transfer makes unfavourable steps favourable (glucose + Pi → glucose 6-phosphate, +13.8 kJ mol⁻¹, becomes −16.7 kJ mol⁻¹ when coupled to ATP); it drives transport (Na⁺/K⁺-ATPase), movement (myosin) and polymer synthesis, where cleavage to AMP + PPi and hydrolysis of PPi by pyrophosphatase make the step effectively irreversible.

🎯 Why AMP is the alarm signal
Adenylate kinase (2 ADP ⇌ ATP + AMP) keeps the adenylates near equilibrium. Because [ATP] is much larger than [AMP], a 10% fall in ATP can raise AMP several-fold, so AMP, which activates phosphofructokinase-1, glycogen phosphorylase b and AMP-activated protein kinase, is the sensitive alarm. Atkinson's energy charge, ([ATP] + ½[ADP])/([ATP] + [ADP] + [AMP]), is held near 0.8–0.95; for 4.0, 0.8 and 0.2 mM it is 4.4/5.0 = 0.88.

Key takeaways

  • Enzymes lower ΔG‡ by binding the transition state more tightly than the substrate; they do not change ΔG°′ or K′eq. Acid–base, covalent, metal-ion and proximity effects add to binding energy, and induced fit and multi-point binding give specificity.
  • v₀ = Vmax[S]/(Km + [S]); Km = (k₋₁ + kcat)/k₁ is the [S] giving Vmax/2; kcat = Vmax/[E]T; kcat/Km measures efficiency, capped by diffusion near 10⁸–10⁹ M⁻¹ s⁻¹. In the Lineweaver–Burk plot the y-intercept is 1/Vmax, the x-intercept −1/Km and the slope Km/Vmax.
  • Sequential two-substrate mechanisms form a ternary complex and give intersecting double-reciprocal lines; ping-pong mechanisms pass through a substituted enzyme and give parallel lines.
  • Competitive inhibitors raise Km (α = 1 + [I]/Ki), uncompetitive ones lower Vmax and Km together, pure noncompetitive ones lower Vmax only; irreversible and suicide inactivators survive dialysis. Statins, methotrexate, aspirin, penicillin and allopurinol are enzyme inhibitors.
  • Flux is controlled at irreversible committed steps by allosteric enzymes (ATCase: CTP inhibits, ATP activates; PFK-1), phosphorylation, zymogen activation, isozymes and enzyme amount; insulin against glucagon, epinephrine and cortisol sets the fed–fasting switch. Water-soluble vitamins are coenzyme precursors, and each deficiency maps to the reactions that fail.
  • ATP hydrolysis has ΔG°′ ≈ −30.5 kJ mol⁻¹ but about −50 to −65 kJ mol⁻¹ in cells, from ΔG = ΔG°′ + RT ln([ADP][Pi]/[ATP]). ATP's intermediate phosphoryl transfer potential makes it the carrier between high-energy donors (PEP, 1,3-BPG, phosphocreatine) and acceptors; AMP and the energy charge report the cell's energy state.

Practice questions (18)

Attempt each one before opening the answer. Every explanation names the tempting wrong option as well as the right one, because that is where marks are lost.

  1. Which statement correctly describes the effect of an enzyme on the reaction it catalyses?

    1. It makes ΔG°′ more negative, so that the equilibrium lies further towards the products
    2. It raises the equilibrium constant by binding the product more tightly than the substrate
    3. It lowers ΔG‡, speeding the forward and reverse reactions equally without changing K′eq
    4. It supplies free energy to the substrate so that an unfavourable reaction proceeds by itself
    Show answer

    Answer: C — It lowers ΔG‡, speeding the forward and reverse reactions equally without changing K′eq

    A catalyst lowers the activation free energy by stabilising the transition state; because the same transition state lies on the forward and reverse paths, both rates rise by the same factor and K′eq (fixed by ΔG°′) is unchanged. An enzyme cannot change ΔG°′ or supply free energy; making an unfavourable reaction go requires coupling to a favourable one, such as ATP hydrolysis, which is a different matter from catalysis.
  2. An enzyme that uses pyridoxal phosphate catalyses L-glutamate + pyruvate ⇌ α-ketoglutarate + L-alanine. To which EC class does it belong?

    1. Oxidoreductases, because glutamate is converted into an α-keto acid in the reaction
    2. Transferases, because an amino group is moved from one molecule to another
    3. Ligases, because a new carbon–nitrogen bond is formed in the alanine product
    4. Lyases, because a group is removed from glutamate without the use of water
    Show answer

    Answer: B — Transferases, because an amino group is moved from one molecule to another

    This is an aminotransferase (transaminase), EC class 2: the amino group passes from glutamate to the enzyme's pyridoxal phosphate and then to pyruvate, with no external electron acceptor such as NAD⁺. The oxidoreductase answer is tempting because glutamate becomes a keto acid, but the electrons stay within the paired substrates. Ligases need ATP, and lyases do not transfer a group to a second substrate.
  3. Glycolysis and gluconeogenesis share most of their enzymes but use different enzymes at three steps. What is the main reason these three glycolytic steps are not simply run in reverse?

    1. The three steps occur in different cell compartments, so a single enzyme could never reach both of its substrates
    2. Gluconeogenesis uses NADPH rather than NADH, so it needs enzymes with a different coenzyme site
    3. The glycolytic enzymes are degraded during fasting and must be replaced by different proteins
    4. Those steps have large negative ΔG in cells, so separate irreversible reactions are needed and allow separate control
    Show answer

    Answer: D — Those steps have large negative ΔG in cells, so separate irreversible reactions are needed and allow separate control

    Hexokinase, phosphofructokinase-1 and pyruvate kinase operate far from equilibrium with large negative ΔG, so their reverse is strongly unfavourable; gluconeogenesis bypasses them with different, also exergonic reactions (pyruvate carboxylase with PEP carboxykinase, fructose 1,6-bisphosphatase, glucose 6-phosphatase). Having distinct enzymes lets the two pathways be regulated reciprocally and avoids futile cycling. The bypass is not explained by NADPH, which gluconeogenesis does not use, nor by enzyme degradation.
  4. An enzyme obeys Michaelis–Menten kinetics. With the same enzyme concentration, the initial rate is 30 µmol min⁻¹ at [S] = 2.0 mM and 50 µmol min⁻¹ at [S] = 6.0 mM. What is Vmax, in µmol min⁻¹?

    Numerical answer — type the value.

    Show answer

    Answer: 75

    Vmax = v₀(Km + [S])/[S] must be the same at both points: 30(Km + 2)/2 = 50(Km + 6)/6, so 15Km + 30 = 8.333Km + 50, giving Km = 3.0 mM. Then Vmax = 15 × (3 + 2) = 75 µmol min⁻¹. Check: 75 × 6/9 = 50. Assuming the higher rate is already Vmax (50) is the usual slip.
  5. A Lineweaver–Burk plot (1/v₀ in min µM⁻¹ against 1/[S] in µM⁻¹) for an enzyme is a straight line with slope 0.040 min and y-intercept 0.0125 min µM⁻¹. What is Km in µM? Give the answer to one decimal place.

    Numerical answer — type the value.

    Show answer

    Answer: 3.2

    y-intercept = 1/Vmax, so Vmax = 1/0.0125 = 80 µM min⁻¹. Slope = Km/Vmax, so Km = 0.040 × 80 = 3.2 µM. Equivalently, the x-intercept is −0.0125/0.040 = −0.3125 µM⁻¹ = −1/Km, giving Km = 3.2 µM.
  6. A purified enzyme at a total active-site concentration of 10 nM gives Vmax = 5.0 µM s⁻¹ and Km = 25 µM. What is its specificity constant kcat/Km, expressed in units of 10⁶ M⁻¹ s⁻¹?

    Numerical answer — type the value.

    Show answer

    Answer: 20

    kcat = Vmax/[E]T = (5.0 × 10⁻⁶ M s⁻¹)/(10 × 10⁻⁹ M) = 500 s⁻¹. kcat/Km = 500/(25 × 10⁻⁶ M) = 2.0 × 10⁷ M⁻¹ s⁻¹ = 20 × 10⁶ M⁻¹ s⁻¹, about a tenth of the diffusion limit. Forgetting to convert µM and nM to M gives answers off by powers of ten.
  7. For an enzyme catalysing A + B → P + Q, initial rates are measured against [A] at several fixed concentrations of B. Which of the following statements are correct?

    1. In a ping-pong mechanism, plots of 1/v₀ against 1/[A] at the different fixed [B] are parallel lines
    2. Lines in such plots that intersect to the left of the 1/v₀ axis show that no ternary complex EAB forms
    3. Aminotransferases are the standard example of an ordered sequential mechanism with a ternary complex
    4. In a ping-pong mechanism the first product leaves before the second substrate binds, leaving a substituted enzyme
    Show answer

    Answer: A — In a ping-pong mechanism, plots of 1/v₀ against 1/[A] at the different fixed [B] are parallel lines; D — In a ping-pong mechanism the first product leaves before the second substrate binds, leaving a substituted enzyme

    In ping-pong kinetics [B] changes only the intercept of the 1/v₀ against 1/[A] plot, so the lines are parallel, and the mechanism passes through a substituted enzyme after the first product leaves. Intersecting lines are the signature of sequential mechanisms, which do form a ternary complex, so that statement is reversed. Aminotransferases are the textbook ping-pong case, carrying the amino group as pyridoxamine phosphate.
  8. In the presence of a drug, the Lineweaver–Burk plot of an enzyme is a line parallel to the control line but shifted upward. What kind of inhibitor is the drug, and how does it change the kinetic constants?

    1. Uncompetitive; it binds only the ES complex and lowers apparent Vmax and Km by the same factor
    2. Competitive; it binds free enzyme at the active site and raises Km while Vmax stays unchanged
    3. Pure noncompetitive; it binds E and ES equally and lowers Vmax while Km stays unchanged
    4. Mixed; it binds E more tightly than ES, so it raises apparent Km and lowers apparent Vmax
    Show answer

    Answer: A — Uncompetitive; it binds only the ES complex and lowers apparent Vmax and Km by the same factor

    An uncompetitive inhibitor divides both Vmax and Km by α′, so the slope Km/Vmax is unchanged and only the intercept 1/Vmax rises: parallel lines. Competitive inhibition changes the slope but not the y-intercept (lines meet on the 1/v₀ axis); pure noncompetitive inhibition changes the slope and y-intercept but not the x-intercept (lines meet on the 1/[S] axis); mixed inhibition gives lines that cross left of the 1/v₀ axis.
  9. At 8.0 µM, a competitive inhibitor raises the apparent Km of an enzyme from 1.5 mM to 4.5 mM and leaves Vmax unchanged. What is the Ki of the inhibitor, in µM?

    Numerical answer — type the value.

    Show answer

    Answer: 4

    For competitive inhibition, apparent Km = αKm with α = 1 + [I]/Ki. α = 4.5/1.5 = 3, so [I]/Ki = 2 and Ki = 8.0/2 = 4 µM. Taking Ki = [I]/α (2.7 µM) is the common slip.
  10. Compound Z lowers the Vmax of an enzyme and leaves its Km unchanged. Which single experiment would best show whether Z is a reversible pure noncompetitive inhibitor or an irreversible inactivator?

    1. Measure initial rates at much higher substrate concentrations to see whether the inhibition is overcome
    2. Dialyse or gel-filter the enzyme–Z mixture and assay again; activity returns only if Z binds reversibly
    3. Draw a Lineweaver–Burk plot and check whether the lines with and without Z meet on the 1/[S] axis
    4. Measure Km at several concentrations of Z and check whether it stays constant as Z increases
    Show answer

    Answer: B — Dialyse or gel-filter the enzyme–Z mixture and assay again; activity returns only if Z binds reversibly

    Both kinds of inhibitor remove a fraction of the enzyme from action without changing the affinity of the rest, so both lower Vmax, leave Km unchanged, are not overcome by substrate and give lines meeting on the 1/[S] axis. Only removal of free Z separates them: a reversible inhibitor dissociates during dialysis or gel filtration and activity returns, whereas a covalently bound inactivator stays attached.
  11. Which of the following statements about drugs that act by inhibiting enzymes are correct?

    1. Statins are uncompetitive inhibitors that bind only the enzyme–substrate complex of HMG-CoA reductase
    2. Aspirin irreversibly inactivates cyclooxygenase by acetylating a serine residue
    3. Allopurinol is converted by xanthine oxidase into oxypurinol, which stays tightly bound and inactivates the enzyme
    4. Methotrexate stops DNA synthesis by covalently alkylating the active site of thymidylate synthase
    Show answer

    Answer: B — Aspirin irreversibly inactivates cyclooxygenase by acetylating a serine residue; C — Allopurinol is converted by xanthine oxidase into oxypurinol, which stays tightly bound and inactivates the enzyme

    Aspirin transfers its acetyl group to a serine of cyclooxygenase, an irreversible covalent change, and allopurinol is a mechanism-based (suicide) inactivator because xanthine oxidase itself makes the tightly bound oxypurinol. Statins resemble HMG-CoA and compete with it at the active site; they are competitive, not uncompetitive. Methotrexate is a folate analogue that binds dihydrofolate reductase extremely tightly and non-covalently; thymidylate synthase is affected only indirectly, through loss of tetrahydrofolate.
  12. Aspartate transcarbamoylase of E. coli shows sigmoidal kinetics, is inhibited by CTP and is activated by ATP. If its catalytic trimers are separated from the regulatory chains and assayed alone, what is observed?

    1. No activity at all, because each active site is built at the interface between a catalytic and a regulatory chain
    2. Sigmoidal kinetics that is inhibited even more strongly by CTP, because the trimers are freed from restraint
    3. Catalytic activity with hyperbolic kinetics that is no longer affected by either CTP or ATP
    4. Sigmoidal kinetics unaffected by ATP but still inhibited by CTP, which binds the catalytic sites
    Show answer

    Answer: C — Catalytic activity with hyperbolic kinetics that is no longer affected by either CTP or ATP

    The active sites lie within the catalytic trimers (between adjacent catalytic chains), so isolated trimers are active. CTP and ATP bind the regulatory chains, so without them there is no feedback control, and the cooperative T⇌R transition of the whole c₆r₆ assembly is lost, giving hyperbolic kinetics. This experiment showed that allosteric and catalytic sites are on different subunits; the claim that CTP acts at the catalytic site is therefore wrong.
  13. In the liver of a fasting person, glucagon raises cAMP and activates protein kinase A. Which consequence helps switch the liver from glycolysis to gluconeogenesis?

    1. PKA phosphorylates the bifunctional PFK-2/FBPase-2, lowering fructose 2,6-bisphosphate
    2. PKA phosphorylates and activates glycogen synthase, so glucose 6-phosphate is stored as glycogen
    3. PKA moves GLUT4 transporters into the hepatocyte membrane so glucose leaves the liver faster
    4. PKA raises fructose 2,6-bisphosphate, which inhibits PFK-1 and diverts fructose 6-phosphate
    Show answer

    Answer: A — PKA phosphorylates the bifunctional PFK-2/FBPase-2, lowering fructose 2,6-bisphosphate

    Phosphorylation of the liver bifunctional enzyme inhibits its kinase (PFK-2) and activates its phosphatase (FBPase-2), so fructose 2,6-bisphosphate falls. Since this compound activates PFK-1 and inhibits fructose 1,6-bisphosphatase, its fall slows glycolysis and speeds gluconeogenesis. Fructose 2,6-bisphosphate activates rather than inhibits PFK-1, so raising it would do the opposite; phosphorylation inactivates glycogen synthase; GLUT4 is an insulin-regulated transporter of muscle and fat, not liver.
  14. Which of the following vitamin – coenzyme – reaction pairings are correct?

    1. Thiamine – thiamine pyrophosphate – carrying one-carbon units for thymidylate synthesis
    2. Vitamin K – reduced vitamin K – hydroxylation of proline residues in collagen
    3. Biotin – enzyme-bound biotin – ATP-dependent carboxylation of pyruvate to oxaloacetate
    4. Pyridoxine – pyridoxal phosphate – transamination of amino acids
    Show answer

    Answer: C — Biotin – enzyme-bound biotin – ATP-dependent carboxylation of pyruvate to oxaloacetate; D — Pyridoxine – pyridoxal phosphate – transamination of amino acids

    Pyruvate carboxylase carries CO₂ on biotin, and aminotransferases use pyridoxal phosphate. One-carbon units for thymidylate are carried by tetrahydrofolate (from folate), not by thiamine pyrophosphate, which serves α-keto acid decarboxylation and transketolase. Prolyl hydroxylation in collagen needs ascorbate (vitamin C); vitamin K serves γ-carboxylation of glutamate in clotting factors.
  15. A man with chronic alcoholism presents with confusion, an unsteady gait and weakness of eye movements. His blood pyruvate and lactate are raised and his erythrocyte transketolase activity is low. Deficiency of which coenzyme best explains these findings?

    1. FAD, which is needed by succinate dehydrogenase and by acyl-CoA dehydrogenase
    2. Pyridoxal phosphate, which is needed for transamination and decarboxylation
    3. Tetrahydrofolate, which carries one-carbon units for purine and thymidylate synthesis
    4. Thiamine pyrophosphate, which is needed by pyruvate dehydrogenase and transketolase
    Show answer

    Answer: D — Thiamine pyrophosphate, which is needed by pyruvate dehydrogenase and transketolase

    The picture is Wernicke's encephalopathy from thiamine deficiency, common in alcoholism. Without thiamine pyrophosphate, pyruvate dehydrogenase fails, so pyruvate accumulates and is reduced to lactate, and transketolase activity (the standard test of thiamine status) falls; the brain, which relies on glucose oxidation, is hit first. Pyridoxal phosphate deficiency would not lower transketolase or block pyruvate oxidation, and folate deficiency presents as megaloblastic anaemia.
  16. In a cell at 310 K, [ATP] = 3.0 mM, [ADP] = 0.30 mM and [Pi] = 3.0 mM. Take ΔG°′ for ATP + H₂O → ADP + Pi as −30.5 kJ mol⁻¹ and R = 8.314 J mol⁻¹ K⁻¹, and ignore activity coefficients and Mg²⁺ binding. What is the actual ΔG of ATP hydrolysis in this cell, in kJ mol⁻¹? Give the answer with its sign, to one decimal place.

    Numerical answer — type the value.

    Show answer

    Answer: -51.4

    Mass-action ratio = [ADP][Pi]/[ATP] = (0.30 × 10⁻³)(3.0 × 10⁻³)/(3.0 × 10⁻³) = 3.0 × 10⁻⁴ (concentrations in M); ln(3.0 × 10⁻⁴) = −8.112. RT = 8.314 × 310 = 2577 J mol⁻¹ = 2.577 kJ mol⁻¹. RT ln Q = −20.91 kJ mol⁻¹. ΔG = −30.5 − 20.91 = −51.4 kJ mol⁻¹. Writing the ratio upside down gives −9.6, a sign that the products and reactants were swapped.
  17. Standard free energies of hydrolysis (ΔG°′, kJ mol⁻¹) are: phosphoenolpyruvate −61.9, phosphocreatine −43.0, ATP to ADP + Pi −30.5, glucose 6-phosphate −13.8 and glycerol 3-phosphate −9.2. Which phosphoryl transfer is favourable under standard conditions?

    1. Glucose 6-phosphate + ADP → glucose + ATP
    2. Phosphoenolpyruvate + ADP → pyruvate + ATP
    3. Creatine + ATP → phosphocreatine + ADP
    4. Glycerol 3-phosphate + ADP → glycerol + ATP
    Show answer

    Answer: B — Phosphoenolpyruvate + ADP → pyruvate + ATP

    For donor-P + ADP → donor + ATP, ΔG°′ = ΔG°′(donor hydrolysis) + 30.5. PEP: −61.9 + 30.5 = −31.4 kJ mol⁻¹, favourable (the pyruvate kinase step). Glucose 6-phosphate: +16.7; glycerol 3-phosphate: +21.3. Making phosphocreatine from ATP: −30.5 + 43.0 = +12.5 kJ mol⁻¹, unfavourable under standard conditions; it proceeds in resting muscle only because of the cellular concentrations.
  18. In working muscle, [ATP] falls by only about 10% while [AMP] rises several-fold, and AMP rather than ATP acts as the main signal that activates phosphofructokinase-1, glycogen phosphorylase b and AMP-activated protein kinase. Why is AMP the more sensitive signal?

    1. Myosin ATPase splits ATP directly into AMP and pyrophosphate during contraction, so AMP reports work done
    2. AMP is the only adenine nucleotide that is able to cross the plasma membrane, so it reports the energy state of the whole body
    3. Adenylate kinase keeps 2 ADP ⇌ ATP + AMP near equilibrium, so with [ATP] ≫ [AMP] a small fall in ATP is a large rise in AMP
    4. AMP binds every ATP site on these enzymes with far higher affinity, so a few AMP molecules displace all the ATP
    Show answer

    Answer: C — Adenylate kinase keeps 2 ADP ⇌ ATP + AMP near equilibrium, so with [ATP] ≫ [AMP] a small fall in ATP is a large rise in AMP

    Adenylate kinase equilibrates the adenylates, so [AMP] ≈ K[ADP]²/[ATP]. When ATP is used, ADP rises and AMP rises roughly with the square of ADP; because AMP starts at a small concentration, its fractional change is many times that of ATP. This amplification makes AMP the alarm signal. Myosin produces ADP + Pi, not AMP; AMP's action is intracellular, not a blood-borne report; and AMP acts at its own allosteric sites rather than displacing ATP from every site.